background: Non-pulmonary vein (non-PV) triggers and left atrial (LA) scars perpetuate atrial fibrillation (AF) and limit the success rate of catheter ablation. As these risk factors manifest in some AF patients and not in all, understanding their genetic basis will offer insight into the inter-individual differences in the clinical presentation and therapeutic approaches of this complex arrhythmia. We examined the association of selected single nucleotide polymorphisms (SNPs) with scar and non-PV triggers. Methods: Four hundred AF patients (67% male, 62\ub112 year, LA size 45.3\ub17 mm, 64% non-paroxysmal) undergoing catheter ablation were prospectively enrolled at our center. DNA extraction and genotyping for 16 AF-related SNPS from blood...
Background<p></p> Genome-wide association studies (GWAS) have identified common genetic...
Background: Cohort studies have revealed an increased risk for ventricular fibrillation (VF) and sud...
BACKGROUND: Atrial fibrillation (AF) results in significant morbidity and mortality. Genome-wide ass...
Purpose: Non-pulmonary vein (non-PV) triggers and left atrial (LA) scars perpetuate atrial fibrillat...
background: Genome-wide association studies have identified several atrial fibrillation (AF)-associa...
ObjectivesThis study tested the hypothesis that chromosome 4q25 single-nucleotide polymorphisms (SNP...
Background: Ablation is a widely used therapy for atrial fibrillation (AF); however, arrhythmia recu...
Background:Ablation is a widely used therapy for atrial fibrillation (AF); however, arrhythmia recur...
Left atrial enlargement and persistent atrial fibrillation (AF) are well-known predictors for arrhyt...
BACKGROUND: Genome-wide association studies (GWAS) have identified common genetic variants that pred...
Abstract Background Previous studies have suggested PITX2, KCNN3 and ZFHX3 as atrial fibrillation (A...
BACKGROUND: Genome-wide association studies (GWAS) have identified common genetic variants that pred...
Background: The ZFHX3 gene (16q22) is the second most highly associated gene with atrial fibrillatio...
Background: Common genetic polymorphisms at chromosome 4q25 were associated with increased susceptib...
Background: Genomewide association studies have identified several loci associated with atrial fibri...
Background<p></p> Genome-wide association studies (GWAS) have identified common genetic...
Background: Cohort studies have revealed an increased risk for ventricular fibrillation (VF) and sud...
BACKGROUND: Atrial fibrillation (AF) results in significant morbidity and mortality. Genome-wide ass...
Purpose: Non-pulmonary vein (non-PV) triggers and left atrial (LA) scars perpetuate atrial fibrillat...
background: Genome-wide association studies have identified several atrial fibrillation (AF)-associa...
ObjectivesThis study tested the hypothesis that chromosome 4q25 single-nucleotide polymorphisms (SNP...
Background: Ablation is a widely used therapy for atrial fibrillation (AF); however, arrhythmia recu...
Background:Ablation is a widely used therapy for atrial fibrillation (AF); however, arrhythmia recur...
Left atrial enlargement and persistent atrial fibrillation (AF) are well-known predictors for arrhyt...
BACKGROUND: Genome-wide association studies (GWAS) have identified common genetic variants that pred...
Abstract Background Previous studies have suggested PITX2, KCNN3 and ZFHX3 as atrial fibrillation (A...
BACKGROUND: Genome-wide association studies (GWAS) have identified common genetic variants that pred...
Background: The ZFHX3 gene (16q22) is the second most highly associated gene with atrial fibrillatio...
Background: Common genetic polymorphisms at chromosome 4q25 were associated with increased susceptib...
Background: Genomewide association studies have identified several loci associated with atrial fibri...
Background<p></p> Genome-wide association studies (GWAS) have identified common genetic...
Background: Cohort studies have revealed an increased risk for ventricular fibrillation (VF) and sud...
BACKGROUND: Atrial fibrillation (AF) results in significant morbidity and mortality. Genome-wide ass...